TY - JOUR
T1 - Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells
AU - Wen, Xiaoyan
AU - Li, Yingjian
AU - Hu, Kebin
AU - Dai, Chunsun
AU - Liu, Youhua
N1 - Funding Information:
Supported by the National Institutes of Health ( grants DK054922, DK061408, and DK064005 ), the American Diabetes Association ( grant 7-03-RA-54 ), and the American Heart Association Pennsylvania-Delaware Affiliate (postdoctoral fellowship to C.D.).
PY - 2005/10
Y1 - 2005/10
N2 - Retinoic acid (RA), an active metabolite of vitamin A, plays a critical role in the regulation of cell proliferation, survival, and differentiation. RA action is primarily mediated through its receptors, ligand-dependent transcription factors of the steroid/thyroid/ vitamin D nuclear receptor superfamily. Recent studies indicate that administration of RA mitigates progressive kidney disease, underscoring its renoprotective potential. In this study, we investigated the effects of 9-cis-RA on glomerular mesangial cell activation induced by transforming growth factor (TGF)-β1 using an in vitro cell culture system. In human mesangial cells 9-cis-RA suppressed TGF-β1-induced α-smooth muscle actin, fibronectin, and plasminogen activator inhibitor-1 expression, but it did not significantly affect cell proliferation and survival. Interestingly, 9-cis-RA induced hepatocyte growth factor (HGF) mRNA expression and protein secretion, stimulated HGF promoter activity, and activated c-met receptor phosphorylation. Similar to HGF, 9-cis-RA induced expression of the Smad transcriptional corepressor TGIF in mesangial cells. Overexpression of exogenous TGIF by transfection or 9-cis-RA treatment suppressed trans-activation of the TGF-β-responsive promoter. Moreover, conditional ablation of the c-met receptor completely abolished the anti-fibrotic effect of 9-cis-RA and abrogated TGIF induction. Collectively, these results indicate that 9-cis-RA possesses anti-fibrotic ability by antagonizing TGF-β1 in mesangial cells and that 9-cis RA activity is likely mediated through a mechanism dependent on HGF/c-met receptor signaling.
AB - Retinoic acid (RA), an active metabolite of vitamin A, plays a critical role in the regulation of cell proliferation, survival, and differentiation. RA action is primarily mediated through its receptors, ligand-dependent transcription factors of the steroid/thyroid/ vitamin D nuclear receptor superfamily. Recent studies indicate that administration of RA mitigates progressive kidney disease, underscoring its renoprotective potential. In this study, we investigated the effects of 9-cis-RA on glomerular mesangial cell activation induced by transforming growth factor (TGF)-β1 using an in vitro cell culture system. In human mesangial cells 9-cis-RA suppressed TGF-β1-induced α-smooth muscle actin, fibronectin, and plasminogen activator inhibitor-1 expression, but it did not significantly affect cell proliferation and survival. Interestingly, 9-cis-RA induced hepatocyte growth factor (HGF) mRNA expression and protein secretion, stimulated HGF promoter activity, and activated c-met receptor phosphorylation. Similar to HGF, 9-cis-RA induced expression of the Smad transcriptional corepressor TGIF in mesangial cells. Overexpression of exogenous TGIF by transfection or 9-cis-RA treatment suppressed trans-activation of the TGF-β-responsive promoter. Moreover, conditional ablation of the c-met receptor completely abolished the anti-fibrotic effect of 9-cis-RA and abrogated TGIF induction. Collectively, these results indicate that 9-cis-RA possesses anti-fibrotic ability by antagonizing TGF-β1 in mesangial cells and that 9-cis RA activity is likely mediated through a mechanism dependent on HGF/c-met receptor signaling.
UR - http://www.scopus.com/inward/record.url?scp=26244432422&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=26244432422&partnerID=8YFLogxK
U2 - 10.1016/S0002-9440(10)61185-6
DO - 10.1016/S0002-9440(10)61185-6
M3 - Article
C2 - 16192631
AN - SCOPUS:26244432422
SN - 0002-9440
VL - 167
SP - 947
EP - 957
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 4
ER -